首页 | 本学科首页   官方微博 | 高级检索  
检索        


Cerebromicrovascular endothelial permeability
Authors:O Kempski  A Villacara  M Spatz  R F Dodson  C Corn  N Merkel  J Bembry
Institution:(1) Laboratory of Neuropathology and Neuroanatomical Sciences, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, 9000 Rockville Pike, Bldg. 36, Rm.4D04, 20892 Bethesda, MD, USA;(2) Department of Cell Biology and Environmental Sciences, The University of Texas, Health Center at Tyler, 75710 Tyler, TX, USA;(3) Present address: Institute for Surgical Research, Universität München, D-8000 München, Germany
Abstract:Summary Permeability of cerebromicrovascular endothelium has been investigated in a new model of cultured cells. The endothelial cells are grown on dextran microcarriers and constitute a barrier for trypan blue (TB) binding to the dextran beads. Changes in the permeability of microcarrier-cultured endothelium have been investigated during the exposure of cells to arachidonic acid or substances involved either in arachidonate metabolism or stimulation of cAMP. The results demonstrate enhanced TB passage through the endothelial barrier during exposure to high concentrations of arachidonic acid and indomethacin, but not to ibuprofen. The effect of indomethacin could be prevented by pretreatment with dexamethasone. Dexamethasone alone did not influence the barrier. Forskolin, a drug which stimulates the catalytic unit of adenylate cyclase, did not affect the endothelial permeability to TB. These findings support the contention that substances derived from a disturbed cellular membrane contribute to the altered blood-brain barrier function found under pathological conditions.Supported in part by a grant from the Deutsche Forschungsgemeinschaft (Ke 3381/1-1) for Dr. Kempski's stay at NIH
Keywords:Cerebromicrovascular endothelium  Arachidonic acid  Indomethacin  Dexamethasone
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号